Brief: ProQR Announces First Quarter 2023 Operating And Financial Results
May 16 (Reuters) - Proqr Therapeutics Nv PRQR.O :
* PROQR ANNOUNCES FIRST QUARTER 2023 OPERATING AND FINANCIAL
RESULTS
* WELL-CAPITALIZED WITH EUR 139 MILLION, IN CASH AND CASH
EQUIVALENTS SUPPORTING RUNWAY INTO MID-2026
* AT MARCH 31, 2023, HELD CASH AND CASH EQUIVALENTS OF EUR
139.0
MILLION
* QTRLY NET LOSS EUR 0.11 PER DILUTED SHARE
* Q1 EARNINGS PER SHARE VIEW EUR -0.11 -- REFINITIV IBES
DATA
Source text for Eikon: ID:nGNX7ccwbS
Further company coverage: PRQR.O
Recent news on ProQR Therapeutics NV
See all newsProQR Therapeutics NV reports results for the quarter ended June 30 - Earnings Summary
ProQR Q2 revenue more than doubles
Brief: ProQR Therapeutics Q2 EPS EUR -0.08
ProQR Therapeutics NV expected to post a loss of 11 cents a share - Earnings Preview
ProQR Therapeutics NV expected to post a loss of 11 cents a share - Earnings Preview